We are live on ! Find out more
DM

Deerfield Management Portfolio holdings

AUM $8.48B
1-Year Est. Return 99.04%
This Fund
S&P 500
This Quarter Est. Return
+12.94%
1 Year Est. Return
+99.04%
3 Year Est. Return
+273.78%
5 Year Est. Return
+280.99%
10 Year Est. Return
+2,168.14%
AUM
$4.11B
AUM Growth
+$673M
Cap. Flow
-$283M
Cap. Flow %
-6.89%
Top 10 Hldgs %
37.55%
Holding
125
New
30
Increased
16
Reduced
24
Closed
24

Top Buys

Rank Stock Value
1
AFIB
Acutus Medical Inc
AFIB
+$132M
2
CALC icon
CalciMedica
CALC
+$78.7M
3
NKTX icon
Nkarta
NKTX
+$71.3M
4
CNC icon
Centene
CNC
+$58.5M
5
OSH
Oak Street Health, Inc.
OSH
+$42.6M

Top Sells

Rank Stock Value
1
SDGR icon
Schrodinger
SDGR
+$123M
2
HOLX
Hologic
HOLX
+$62.2M
3
MCK icon
McKesson
MCK
+$42.7M
4
SILK
Silk Road Medical, Inc. Common Stock
SILK
+$31.2M
5
PCRX icon
Pacira BioSciences
PCRX
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 62.18%
2 Financials 1.23%
3 Industrials 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
51
Protagonist Therapeutics
PTGX
$8.8B
$23.1M 0.56%
1,179,971
+166,476
+16% +$3.12M
LGVW.U
52
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
$22.3M 0.54%
2,200,000
– –
CNST
53
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$20.4M 0.5%
1,005,487
+131,597
+15% +$3.21M
NNOX icon
54
Nano X Imaging
NNOX
$61.1M
$17.9M 0.44%
+762,000
New +$25.5M
ALEC icon
55
Alector
ALEC
$169M
$15.4M 0.38%
1,461,978
-215,019
-13% -$3.48M
BCRX icon
56
BioCryst Pharmaceuticals
BCRX
$2.48B
$15.3M 0.37%
4,456,519
– –
SLQT icon
57
SelectQuote
SLQT
$132M
$15.2M 0.37%
750,000
– –
NTRA icon
58
Natera
NTRA
$36.1B
$15.1M 0.37%
208,333
-115,705
-36% -$6.58M
ARVN icon
59
Arvinas
ARVN
$529M
$14.5M 0.35%
614,156
-394,500
-39% -$11.4M
ATNX
60
DELISTED
Athenex, Inc. Common Stock
ATNX
$13.9M 0.34%
+57,500
New +$13.8M
ARDX icon
61
Ardelyx
ARDX
$1.25B
$13.4M 0.33%
2,561,554
– –
RNAM
62
DELISTED
Avidity Biosciences
RNAM
$13.3M 0.33%
474,186
-402,825
-46% -$11.6M
TARA icon
63
Protara Therapeutics
TARA
$221M
$13.2M 0.32%
782,670
+350,000
+81% +$8.12M
LUMO
64
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$12.9M 0.32%
936,291
+122
+0% +$1.82K
PROF
65
Profound Medical
PROF
$263M
$12.3M 0.3%
+695,000
New +$11M
SEM
66
DELISTED
Select Medical
SEM
$11.8M 0.29%
1,048,640
– –
FUSN
67
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$11.7M 0.28%
972,046
-284,954
-23% -$3.89M
ELVN icon
68
Enliven Therapeutics
ELVN
$3.84B
$10.5M 0.26%
129,413
+23,413
+22% +$2.11M
ITMR
69
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
$10.2M 0.25%
499,136
– –
CAPAU
70
DELISTED
HighCape Capital Acquisition Corp. Unit
CAPAU
$10.1M 0.25%
+1,000,000
New +$10.1M
ADCT icon
71
ADC Therapeutics
ADCT
$141M
$9.9M 0.24%
300,000
-200,000
-40% -$8.66M
MTCR
72
DELISTED
Metacrine, Inc. Common Stock
MTCR
$9.47M 0.23%
+927,469
New +$9.49M
GOCO
73
DELISTED
GoHealth
GOCO
$9.12M 0.22%
+46,667
New +$11.2M
LONA
74
LeonaBio Inc
LONA
$65.5M
$8.31M 0.2%
+45,000
New +$7.52M
DYN icon
75
Dyne Therapeutics
DYN
$4.28B
$8.3M 0.2%
+411,267
New +$9.03M
1 2
3
4 5

Similar funds

FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $8.52B AUM 37.76% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $8.42B AUM 14.36% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $8.4B AUM 63.34% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Deerfield Management's Q3 2020 Portfolio in Review

As of Q3 2020, Deerfield Management held 125 positions worth $4.11B, up 20% from $3.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Deerfield Management withdrew a net $283M in Q3 2020, closing 24 positions and reducing 24 holdings. Its most notable exit was Schrodinger, an estimated $123M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 62% of assets, down from 66% a quarter earlier, followed by Financials and Industrials.

Against the trend, Deerfield Management opened a new position in Acutus Medical Inc worth $129M.

  • Deerfield Management's largest Q3 2020 buy was Acutus Medical Inc: 4,341,799 shares worth $129M.
  • Deerfield Management added most to Centene in Q3 2020, an estimated $58.5M increase.
  • Deerfield Management's biggest Q3 2020 reduction was Hologic, cutting an estimated $62.2M.
  • Deerfield Management fully exited Schrodinger in Q3 2020, selling an estimated $123M.
  • Deerfield Management's ten largest holdings make up 38% of its $4.11B portfolio in Q3 2020.
  • Deerfield Management opened 30 new positions and closed 24 in Q3 2020.
  • Deerfield Management's portfolio value rose 20% quarter-over-quarter to $4.11B.

Based on Deerfield Management's 13F filing for Q3 2020, filed 16 Nov 2020.